Risk of metabolic disorders in childless men:a population-based cohort study by Bungum, Ane Berger et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Risk of metabolic disorders in childless men
Bungum, Ane Berger; Glazer, Clara Helene; Bonde, Jens Peter; Nilsson, Peter M;
Giwercman, Aleksander; Søgaard Tøttenborg, Sandra
Published in:
BMJ Open
DOI:
10.1136/bmjopen-2017-020293
Publication date:
2018
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY
Citation for published version (APA):
Bungum, A. B., Glazer, C. H., Bonde, J. P., Nilsson, P. M., Giwercman, A., & Søgaard Tøttenborg, S. (2018).
Risk of metabolic disorders in childless men: a population-based cohort study. BMJ Open, 8(8), 1-7. [e020293].
https://doi.org/10.1136/bmjopen-2017-020293
Download date: 03. Feb. 2020
1Bungum AB, et al. BMJ Open 2018;8:e020293. doi:10.1136/bmjopen-2017-020293
Open access 
Risk of metabolic disorders in childless 
men: a population-based cohort study
Ane Berger Bungum,1,2 Clara Helene Glazer,1 Jens Peter Bonde,1 Peter M Nilsson,3 
Aleksander Giwercman,2 Sandra Søgaard Tøttenborg1
To cite: Bungum AB, 
Glazer CH, Bonde JP, et al.  
Risk of metabolic disorders in 
childless men: a population-
based cohort study. BMJ Open 
2018;8:e020293. doi:10.1136/
bmjopen-2017-020293
 ► Prepublication history and 
additional material for this 
paper are available online. To 
view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2017- 
020293).
Received 27 October 2017
Revised 17 May 2018
Accepted 9 July 2018
1Department of Occupational 
and Environmental Medicine, 
Bispebjerg University Hospital, 
Kobenhavn, Denmark
2Molecular Reproductive 
Medicine, Department of 
Translational Medicine, Lund 
University, Malmö, Sweden
3Department of Clinical Sciences 
Malmö, Lund University, Skåne 
University Hospital, Malmö, 
Sweden
Correspondence to
Ane Berger Bungum;  
 ane. berger. bungum@ regionh. dk
Research
© Author(s) (or their 
employer(s)) 2018. Re-use 
permitted under CC BY. 
Published by BMJ.
AbstrACt
Objective To study whether male childlessness is 
associated with an increased risk of metabolic disorders 
such as metabolic syndrome (MetS) and diabetes.
Design A population-based cohort study.
setting Not applicable.
Participants 2572 men from the population-based 
Malmö Diet and Cancer Cardiovascular Cohort.
Interventions None.
Main outcome measures From cross-sectional analyses, 
main outcome measures were ORs and 95% CIs for 
MetS and diabetes among childless men. In prospective 
analyses, HRs and 95% CI for diabetes among childless 
men.
results At baseline, in men with a mean age of 57 
years, the prevalence of MetS was 26% and 22% among 
childless men and fathers, respectively. Similarly, we 
observed a higher prevalence of diabetes of 11% among 
childless men compared with 5% among fathers. In the 
cross-sectional adjusted analyses, childless men had a 
higher risk of MetS and diabetes, with ORs of 1.22 (95% 
CI 0.87 to 1.72) and 2.12 (95% CI 1.34 to 3.36) compared 
with fathers. In the prospective analysis, during a mean 
follow-up of 18.3 years, we did not see any increase in 
diabetes risk among childless men (HR 1.02 (0.76 to 
1.37)).
Conclusion This study provides evidence of an 
association between male childlessness and a higher risk 
of MetS and diabetes. However, as these associations 
were found in cross-sectional analyses, reverse causation 
cannot be excluded.
IntrODuCtIOn 
A man’s reproductive health may not only 
reflect his chance to become a father, but 
may also be related to his general health.1 
In recent years, male childlessness and infer-
tility have been reported to be associated 
with an increased risk of all-cause mortality 
and cardiovascular disease.2–5 Male infertility 
has also been associated with a higher risk of 
metabolic disorders.3 6 7 Metabolic syndrome 
(MetS) and type 2 diabetes are metabolic 
disorders, with increasing prevalence world-
wide.8 9 MetS is a syndrome consisting of a 
cluster of markers, including visceral obesity, 
hypertension and hyperglycaemia.8 Impor-
tantly, the syndrome may help to identify 
individuals at future risk of type 2 diabetes 
and cardiovascular disease.10–12 
Cross-sectional studies have demonstrated 
an association between factors related to 
male reproductive health (eg, hypogo-
nadism, reduced semen quality and erec-
tile dysfunction) and MetS, as well as type 2 
diabetes,13–18 but whether poor reproduc-
tive health precedes MetS and diabetes or 
vice versa is uncertain due to the cross-sec-
tional design of these studies. Two recent 
prospective studies found increased risk of 
developing diabetes among infertile men.3 7 
Authors of these prospective studies did not 
suggest a causal relationship for the associa-
tion, but rather common aetiologies of infer-
tility and diabetes such as shared genetics and 
factors related to endocrine regulation, life-
style or in-utero exposures. However, these 
prospective studies failed to adjust for body 
mass index (BMI), physical activity level and 
other lifestyle factors considered as common 
risk factors for type 2 diabetes and poor 
male reproductive health.11 19 Also, as type 2 
diabetes can remain asymptomatic and undi-
agnosed for years, the measure of outcome 
of both prospective studies have a central 
strengths and limitations of this study
 ► Malmö Diet and Cancer Cardiovascular Cohort is 
sampled from the background urban population, 
meaning that men from all socioeconomic back-
grounds were represented.
 ► This study has the longest mean follow-up among 
similar studies published.
 ► Childlessness was associated with increased risks 
of metabolic  syndrome and diabetes in cross-sec-
tional analyses but not in prospective analyses. 
Using childlessness as a proxy of infertility may 
pose some challenges as the group of childless men 
is heterogeneous in relation to different causes of 
childlessness.
 ► We were unable to distinguish between fathers of 
biological or adopted children and fathers of children 
conceived after in vitro fertilisation.
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limitation in common; dependence on health-seeking 
behaviour of the study participants.
Assessment of fertility status of a man is based on access 
to clinical and laboratory data, including semen analysis, 
which are difficult and costly to obtain in population-based 
studies. However, information regarding childlessness 
is more easily accessible and may be a feasible proxy for 
infertility. Therefore, using data from the Malmö Diet 
and Cancer Cardiovascular Cohort (MDC-CC), we aimed 
to examine whether male childlessness is associated with 
MetS and diabetes, while taking potential confounding 
lifestyle factors into account. We first examined the prev-
alence of MetS and diabetes in men with and without 
children, and next we assessed the incidence of diabetes 
during a mean follow-up of 18.3 years. Study partici-
pants were examined for diabetes both at baseline and 
follow-up clinical examination, limiting the influence of 
health-seeking behaviour and giving reliable estimates 
of diabetes prevalence and incidence among childless 
Swedish men.
MAterIAls AnD MethODs
study population
The Malmö Diet and Cancer Cohort (MDC) is a 
population-based cohort of 30 446 Malmö residents 
(12 120 men born between 1926 and 1945 and 18 326 
women born between 1923 and 1950) enrolled during 
1991-1996.20 The participation rate was 38% for men.21 
Following the initial acceptance letter, during the years 
of 1991–1994, half of the individuals in MDC randomly 
selected were invited to participate in a subcohort named 
MDC-CC. Of these, 2572 men accepted the invitation 
(figure 1).
Both at baseline (1991–1994) and follow-up (2007–
2012), MDC-CC participants completed a questionnaire 
regarding marital status, number of children and life-
style factors (alcohol (g/day), smoking habits (regularly, 
occasionally, stopped, never) and total physical activity 
score (according to the Minnesota Leisure Time Physical 
Activity Questionnaire22—calculated as minutes/week 
for spring/summer/autumn/winter multiplied with an 
activity-specific factor according to the type of activity, eg, 
running, walking). Participants also underwent a clinical 
examination including body composition, blood pressure 
measurement and collection of venous blood samples.21 
At follow-up examination where 1522 men (59%) partic-
ipated, the clinical examination also included an oral 
glucose tolerance test in study participants without known 
diabetes.
Patient and public involvement
Patients and or public were not involved.
Information on childlessness
Information regarding childlessness came from two 
sources: the baseline questionnaire and the Swedish Tax 
Agency (STA). In the questionnaire, participants were 
asked ‘Do you have any children?’ with reply options ‘Yes’ 
or ‘No’. The STA holds the number of registered chil-
dren and their respective birth dates. Data were linked 
using the unique 10-digit personal identification number 
assigned to all Swedish citizens. We linked these data 
sources to stratify the participants into four groups: 
‘Childless’, ‘One or more child’, ‘Conflicting informa-
tion’ and ‘Unknown’. ‘Conflicting information’ appeared 
if a participant answered ‘No’ to ‘Do you have any children?’ 
in the baseline questionnaire, but was registered with 
Figure 1 Malmö Diet and Cancer Cardiovascular Cohort (MDC-CC) recruitment.
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one or more children in the STA. Men with ‘Conflicting 
information’ who became fathers after the entry date 
into the MDC-CC cohort were treated as ‘Childless’ as 
they were childless at baseline. The remaining men with 
‘Conflicting information’ were registered as fathers in 
the registry of STA and were therefore treated as having 
‘One or more child’. We used the designation ‘Unknown’ 
if no information regarding children was available from 
the STA and if no answer was provided to ‘Do you have any 
children?’ in the baseline questionnaire.
Assessment of Mets
MetS was defined according to the harmonised criteria 
of the International Diabetes Federation Task Force on 
Epidemiology and Prevention; National Heart, Lung, 
and Blood Institute; American Heart Association; World 
Heart Federation; International Atherosclerosis Society; 
and International Association for the Study of Obesity.23 
Accordingly, MetS was present if three or more of 
the following criteria were met: fasting blood glucose 
(fB-glucose) level above 5.6 mmol/L or the use of anti-
diabetic drugs, high-density lipoprotein cholesterol level 
below 1.03 mmol/L or the use of lipid-modifying treat-
ment, triglycerides level above 1.7 mmol/L or the use of 
lipid-lowering drugs, waist circumference higher than 
102 cm and blood pressure above 130/85 mm Hg or the 
use of antihypertensive medicine.23 Data regarding MetS 
criteria were only available from the baseline clinical 
examination.
Diagnosis of diabetes
The diabetes cases and the date of diagnosis were 
identified from 14 different data sources, including 
the Swedish National Diabetes Register (NDR), The 
Swedish Prescribed Drug Register, and from baseline and 
follow-up screenings in MDC, MDC-CC and the Malmö 
Preventive Project (MPP).24 These sources were used to 
identify prevalent cases of diabetes (type 1 and type 2) at 
baseline and new-onset incident cases of diabetes (type 
1 and type 2) during the follow-up period. In brief, indi-
viduals with a date of diagnosis registered in the NDR 
and/or Diabetes 2000 Register were considered to have 
diabetes. The same was true for individuals in the local 
haemoglobin A1c (HbA1c) Register in Malmö with at least 
two HbA1c ≥6%, those with the Tenth Edition of Interna-
tional Classification of Diseases (ICD10) codes E10-E14 
and O244-O249, and corresponding ICD7-9 codes in 
the National Hospitalisation Register or in the Cause-of-
Death Register, and men in The Swedish Prescribed Drug 
Register with Anatomical Therapeutic Chemical code 
A10.
From baseline questionnaires of MDC and MPP, partic-
ipants who answered ‘Yes’ to ‘Do you have diabetes?’ and/
or listed antidiabetic drugs were considered as patients 
with diabetes. At the baseline examination of MDC-CC, 
individuals were considered having diabetes if the fB-glu-
cose measurement was ≥6.5 mmol/L. In MPP and at 
the MDC-CC follow-up, fB-glucose ≥6.5 mmol/L had 
to be verified through oral glucose tolerance test and/
or fasting plasma glucose measurements. A full list of 
the diabetes diagnostic sources is provided in online 
supplementary table I. The participants were considered 
as having diabetes from their first diagnosis of diabetes 
while any and subsequent contradictory information 
about diabetes was ignored.25
statistical analyses
Cross-sectional analysis
To assess the association between male childlessness and 
metabolic disorders, the prevalence of MetS and diabetes 
at baseline 1991–1996 was compared among men with 
and without children by means of logistic regression and 
reported as ORs with corresponding 95% CIs. As child-
lessness could be a function of not having a partner, 
sensitivity analyses including only married men were also 
performed.
Prospective analysis
To assess whether the possible association between male 
childlessness and diabetes persisted or attenuated later in 
life, HR with 95% CIs of diabetes among childless men 
compared with fathers were computed using Cox propor-
tional hazard models. Men with pre-existing diabetes at 
baseline were excluded. The men were followed from 
enrolment into the MDC-CC until date of diabetes 
diagnosis, emigration, death or end of follow-up (31 
December 2014). Kaplan-Meier plots allowed for visual 
evaluation of proportional hazards assumption. As with 
the cross-sectional analysis, we completed a sensitivity 
analysis, including only married men.
Potential confounders were identified a priori using 
directed acyclic graphs.26 Adjustments were performed in 
two steps in all analyses. The first adjustment step (model 
I) included age in years, marital status (married/unmar-
ried/divorced/widower), socioeconomic index (workers, 
unskilled/workers, skilled/lower positioned official or 
salaried/intermediate positioned official or salaried/
employers or self-employed) and educational attainment 
(no education/primary school/secondary school/high 
school/>1 year education after high school/university 
degree). The second adjustment step (model II) also 
included BMI in kg/m2, alcohol consumption in grams 
per day, smoking habits (regularly smoker/occasional 
smoker/stopped smoking/never smoked) and physical 
activity level in minutes per week. The reason for the 
distinction between model I and model II is that it can be 
argued that BMI, alcohol consumption, smoking habits 
and physical activity level mediates rather than confound 
the association between childlessness, MetS and diabetes. 
For instance, smoking habits can affect a man’s reproduc-
tive health, but on the contrary if a man becomes a father, 
this can affect his smoking habits.
In the statistical analyses, probability values (p values) 
were not included, instead 95% CI for measures of associ-
ation were reported to display the measure of precision.27 
All statistical tests were performed using SAS V.9.4.
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results
Among all 2572 men, 422 had missing information 
regarding fatherhood status and were excluded from 
analyses. Twenty men had ‘Conflicting information’ 
regarding fatherhood, of which 18 men had registered 
children in the STA before baseline, and two men became 
fathers after baseline and thus treated as ‘Childless’. 
Consequently, 2150 men were included in the analyses of 
which 15% were childless and 85% fathers (table 1). The 
mean age in the cohort was 57 years at baseline. The base-
line sociodemographic and lifestyle characteristics were 
equally distributed in general among childless men and 
fathers, except for the distribution of marital status, with 
81% of fathers being married compared with only 37% of 
childless men being married.
Association between childlessness, Mets and diabetes
MetS
The prevalence of MetS at baseline was 26% among child-
less men and 22% among fathers. The major contributing 
factor for MetS among childless men was hyperglycaemia 
(table 2). The fully adjusted analyses (model II) indicated 
an increased risk of MetS in childless men compared with 
fathers, (OR 1.22, 95% CI 0.87 to 1.72) (table 3). When 
comparing married childless men to married fathers, the 
association became stronger and statistically significant 
with OR 1.62 (95% CI 1.01 to 2.60) in the fully adjusted 
model (table 3).
Diabetes
The prevalence of diabetes at baseline, was 11% among 
childless men and 5% among fathers. In the fully adjusted 
analysis (model II), childless men had a higher risk of 
diabetes compared with fathers with OR 2.12 (95% CI 
1.34 to 3.36) (table 4). The association persisted when 
comparing married fathers to married childless men 
(table 4).
risk of developing diabetes
The occurrence of new cases of diabetes was 20% among 
childless men and 22% among fathers. The mean 
follow-up time was 18.3 years. The fully adjusted analysis 
(model II) showed no increased risk of diabetes in child-
less men compared with fathers (table 5). However, the 
sensitivity analysis including only married men suggested 
an increased risk of diabetes among childless men 
Table 1 Sociodemographic and lifestyle characteristics of 
men with and without children at baseline
Childless men
(n=333)
Fathers
(n=1817)
Age (years) (n=2 150) 57.3 (6.1) 57.1 (5.9)
Marital status  (n=2052)
  Married (%) 51 81
  Unmarried (%) 8 3
  Divorced (%) 4 14
  Widower (%) 37 2
Socioeconomic index  (n=1927)
  Employers and self-
employed (%)
16 22
  Official/salaried, 
intermediate position (%)
21 24
  Official/salaried, lower 
position (%)
21 15
  Workers, skilled (%) 17 21
  Workers, unskilled (%) 25 18
Highest level of education  (n=2056)
  No education (%) 0 1
  Primary school (%) 50 45
  Secondary school (%) 22 20
  High school (%) 11 12
  >1  year education after 
high school (%)
7 10
  University degree (%) 10 12
Body Mass Index (kg/m2) 
(n=2148)
26 (4.1) 26.1 (3.3)
Alcohol (g/day) (n=2057) 14.6 (18.4) 15.8 (15.2)
Present smoker (n=2058)
  Regularly (%) 24 22
  Occasionally (%) 4 5
  Stopped (%) 38 43
  Never (%) 34 30
Physical activity score* 
(n=2 041)
8675.3 (6771.0) 8361.9 (6224.9)
Means (SD) and proportions.
*Min/week for spring/summer/autumn/winter multiplied with 
an activity-specific factor according to the type of activity, for 
example, running, walking.
Table 2 OR with 95% CI of MetS components in childless 
men (n=333) compared with fathers (n=1 817) at baseline
No of cases 
among childless 
men (vs fathers) OR (95% CI)
Hyperglycaemia* 88 (335) 1.59 (1.21 to 2.08)
Hypo-HDL 
cholesterolaemia†
102 (670) 0.78 (0.60 to 1.01)
Hyperlipidaemia‡ 97 (515) 1.04 (0.80 to 1.34)
Waist 
circumference >102 cm
54 (270) 1.11 (0.81 to 1.53)
Hypertension§ 222 (1160) 1.13 (0.88 to 1.45)
*Hyperglycaemia defined as a fasting blood glucose 
level ≥5.6 mmol/L or by the use of antidiabetic medicine.
†Hypo-HDL cholesterolaemia defined as HDL <1.03 mmol/L or 
by the use of drug treatment.
‡Hyperlipidaemia defined as triglycerides ≥1.7 mmol/L or by 
the use of lipid-lowering drugs.
§Hypertension (elevated blood pressure) defined by 
≥130/85 mm Hg or by the use of antihypertensive drugs.
BMI, body mass index; HDL, high-density lipoprotein; MetS, 
metabolic syndrome. 
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compared with fathers (HR 1.13, 95% CI 0.74 to 1.73) 
(table 5).
DIsCussIOn
Main findings
Our study demonstrates cross-sectional associations 
between male childlessness, MetS and diabetes. As 
expected, associations were generally stronger in anal-
yses restricted to married men where a lack of reproduc-
tive opportunities could have been accounted for. The 
increased risk of MetS and diabetes among childless men 
could not be attributed to differences in lifestyle or socio-
demographic characteristics between childless men and 
fathers.
Prior literature
Our findings are comparable with other cross-sectional 
studies reporting higher rates of medical comorbidities, 
poorer general health status and type 2 diabetes among 
infertile men.15 28–30 However, whether infertility comes 
before diabetes or MetS and vice versa is still unclear. Some 
studies suggest hyperglycaemia which is a central element 
in both diabetes and MetS to affect the endocrine control 
of male reproductive function, and to impair spermato-
genesis, sperm maturation, erectile function and ejacula-
tion,11 13 31 and this makes reverse causation of our study 
plausible but results regarding the impact of MetS and 
diabetes on semen quality are conflicting.13 32
Furthermore, our cross-sectional findings are also 
consistent with reports from the USA3 and Denmark7 
that show male factor infertility to be associated with a 
30%–45% higher risk of diabetes in prospective analyses, 
where the chance of reverse causation is highly limited, as 
exposure precedes outcome. Findings of these prospec-
tive studies are also supported by a recent Danish study33 
which found higher hospitalisation rates for diabetes 
among men with poor semen quality and the authors of 
these latter mentioned studies suggested common aetiol-
ogies for male infertility, poor semen quality and diabetes. 
Our prospective results which showed no additional 
increase in risk can seem contradictory, but the mean age 
of the study population was more than 20 years higher 
Table 3 OR with 95% CI for MetS in childless men relative to fathers
Total population 
(n=2150) Crude Model I* Model II†
n cases OR (95% CI) OR (95% CI) OR (95% CI)
Fathers (n=1 817) 402 (22.1%) 1 (ref) 1 (ref) 1 (ref)
Childless men (n=333) 85 (25.5%) 1.21 (0.92 to 1.58) 1.22 (0.92 to ;1.64) 1.22 (0.87 to 1.72)
Only married men 
(n=1515) Crude Model I‡ Model II§
n cases OR (95% CI) OR (95% CI) OR (95% CI)
Fathers (n=1 392) 317 (22.8%) 1 (ref) 1 (ref) 1 (ref)
Childless men (n=123) 42 (34.2%) 1.76 (1.19 to 2.61) 1.66 (1.11 to 2.49) 1.62 (1.01 to 2.60)
*Model 1: adjusted for age, marital status, SEI and education (n=1 923).
†Model 2: adjusted for age, marital status, SEI, education, BMI, alcohol (g/day), smoking and physical activity score (n=1 895).
‡Model I: adjusted for age, SEI and education (n=1 414).
§Model II: adjusted for age, SEI, education, BMI, alcohol (g/day), smoking and physical activity score (n=1 396).
BMI, body mass index; MetS, metabolic syndrome; SEI, socioeconomic index. 
Table 4 OR with 95% CI for diabetes in childless men relative to men with children
Total population 
(n=2150) n cases
Crude Model I* Model II†
OR (95% CI) OR (95% CI) OR (95% CI)
Fathers (n=1 817) 87 (4.8%) 1 (ref) 1 (ref) 1 (ref)
Childless men (n=333) 35 (10.5%) 2.34 (1.55 to 3.52) 2.26 (1.44 to 3.54) 2.12 (1.34 to 3.36)
Only married 
men  (n=1515) n cases
Crude Model I‡ Model II§
OR (95% CI) OR (95% CI) OR (95% CI)
Fathers (n=1 392) 64 (4.6%) 1 (ref) 1 (ref) 1 (ref)
Childless men (n=123) 13 (10.6%) 2.45 (1.30 to 4.59) 2.29 (1.18 to 4.43) 2.05 (1.03 to 4.08)
*Model I: adjusted for age, marital status, SEI and education (n=1 923).
†Model II: adjusted for age, marital status, SEI, education, BMI, alcohol (g/day), smoking and physical activity score (n=1 895).
‡Model I: adjusted for age, SEI and education (n=1 414).
§Model II: adjusted for age, SEI, education, BMI, alcohol (g/day), smoking and physical activity score (n=1 396).
BMI, body mass index; SEI, socioeconomic index. 
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than in the mentioned studies, and this makes detection 
of early onset of diabetes difficult.
Mechanisms
The relationship between male reproductive health 
and somatic health is rather complex and different 
causal mechanisms and common aetiologies have been 
proposed for the association, namely shared genetic 
origins, in utero, hormonal or environmental/lifestyle 
factors.1–3 7 33 More than 150 genes are linked to male 
infertility and simultaneously involved in pathways 
important for several diseases, such as cancer, cardiovas-
cular and metabolic disorders.34 Also, as male germ cell 
differentiation includes expression of up to 4% of all 
mammalian genes, it seems plausible that mutations in 
these genes could cause or contribute both to infertility, 
MetS and diabetes.35 Further, as our cross-sectional results 
display a strong increase in risk of diabetes until the mean 
age of 57 years, and no additional increase in diabetes 
risk hereafter, as seen in our prospective results, this 
points to early onset of diabetes and support the hypoth-
esis of genetic origins, as genetic predisposition increases 
the risk of early onset type 2 diabetes.36 In addition to 
genetic defects, maternal health behaviour and environ-
mental exposures during pregnancy have been hypothe-
sised to act directly or through epigenetic mechanisms on 
the fetus and thereby influence both male reproductive 
health and somatic health.2 37
Low testosterone levels have also been associated with 
infertility and an increased risk of MetS and diabetes, as 
testosterone plays an import role in glucose and lipid 
metabolism.38–40 One study found low testosterone to 
predict development of MetS and onset of diabetes, even 
after adjusting for BMI, insulin resistance and other 
established risk factors for these conditions.39 41 Another 
study among men with infertility problems and decreased 
sperm counts, reported low testosterone levels to be asso-
ciated with higher levels of HbA1c.
42 However, obesity, 
which is a strong risk factor for MetS and diabetes, is 
also known to lower testosterone levels, as testosterone 
is converted to oestradiol in adipose tissue. On the other 
hand, low testosterone levels are also known to increase 
obesity.43 The causality of the relationship between low 
testosterone, MetS and diabetes is therefore unclear but 
may be bidirectional.38
Low socioeconomic status and adverse lifestyle factors 
have been suspected to explain the association between 
poor reproductive health and somatic health. In the 
present study, we adjusted for multiple lifestyle factors 
and socioeconomic status, and associations were still 
seen. However, the operationalisation of lifestyle factors 
may not sufficiently reduce the risk of confounding in 
the analysis of diabetes risk among childless men. This 
is due to the fact that information on lifestyle factors 
were only obtained at baseline and men with a diabetes 
diagnosis prior to baseline could have changed their life-
style according to the disease. This makes it impossible to 
distinguish between prediagnostic lifestyle and postdiag-
nostic lifestyle, and only the lifestyle related to both expo-
sure and outcome, namely the prediagnostic lifestyle, 
qualifies as a confounder. This may have induced some 
residual confounding in the analysis of diabetes risk, but 
not in the analysis of MetS risk as the diagnosis was based 
on information collected at baseline. Furthermore, our 
prospective analyses, which did not display the same asso-
ciation as our cross-sectional analyses, could also be influ-
enced by results of clinical examination at baseline, and 
a wish among childless men to live a healthier life style. 
Data regarding MetS criteria were only available from the 
baseline clinical examination, why a prospective analysis 
of the association between childlessness and MetS could 
not be performed.
strengths and limitations
The present study has several strengths. First, the 
MDC-CC is sampled from the background urban popu-
lation, meaning that men from all socioeconomic back-
grounds were represented. A previous study showed no 
difference in baseline sociodemographic characteristics 
compared with study participants in the MDC.21 Also, 
among Swedish men born between 1935 and 1945, one 
in six remained childless44 which is comparable with the 
Table 5 HR with 95% CI for diabetes in childless men relative to fathers
Total 
population  (n=2028) n cases
Crude Model I* Model II†
HR (95% CI) HR (95% CI) HR (95% CI)
Fathers (n=1 730) 373 (21.6%) 1 (ref) 1 (ref) 1 (ref)
Childless men (n=298) 60 (20.1%) 1.05 (0.80 to 1.38) 1.12 (0,85 to 1.49) 1.02 (0.76 to 1.37)
Only married 
men  (n=1438) n cases
Crude Model I‡ Model II§
HR (95% CI) HR (95% CI) HR (95% CI)
Fathers (n=1 328) 281 (21.2%) 1 (ref) 1 (ref) 1 (ref)
Childless men (n=110) 24 (21.8%) 1.17 (0.77 to 1.77) 1.20 (0,79 to 1.83) 1.13 (0.74 to 1.73)
*Model I: adjusted for age, marital status, SEI and education (n=1 820).
†Model II: adjusted for age, marital status, SEI, education, BMI, alcohol (g/day), smoking and physical activity score (n=1 794).
‡Model I: adjusted for age, SEI and education (n=1 346).
§Model II: adjusted for age, SEI, education, BMI, alcohol (g/day), smoking and physical activity score (n=1 330).
BMI, body mass index; SEI, socioeconomic index. 
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proportion of childless men in our cohort. Second, the 
mean cohort age at baseline was already advanced, and 
childlessness at an advanced age strengthens the assump-
tion of infertility. Third, the valid and comprehensive 
national Swedish registers provided information on 
emigrations, death and disease-limited loss to follow-up 
and made long-term follow-up of more than 18 years in 
average possible—the longest mean follow-up among the 
few similar studies published to date.3 7 33
Our study also has limitations. As for cross-sectional 
studies in general, data regarding exposure and outcome 
were collected simultaneously, making it impossible to rule 
out reverse causation, However, as previously mentioned, 
studies have reported prospective associations between 
male infertility and risk of diabetes, in younger study 
populations than the present cohort,3 7 33 and the chance 
of reverse causation in prospective studies is low.
Furthermore, using childlessness as a proxy of infer-
tility poses some challenges. The group of childless men 
is heterogeneous in relation to different causes of child-
lessness and do not only reflect male infertility (eg, volun-
tarily childlessness, homosexual men, men with infertile 
partners or single men). As only one in four childless 
Swedish men reported childlessness to be volitional,44 
this limits the risk of our sample to reflect voluntary 
childlessness.
Also, we were unable to distinguish between fathers of 
biological or adopted children and fathers of children 
conceived after in vitro fertilisation (IVF). However, as 
adoption rates in Sweden were rather low at the time of 
baseline,45 misclassification would attenuate the estimate 
towards the null. Likewise, the chance of having children 
conceived after IVF was insignificant as assisted reproduc-
tion as treatment of impaired male fertility was not widely 
performed before and at the time of baseline in 1991–
1994.46 This strengthens the usefulness of childlessness as 
a proxy for infertility in the present cohort.
Misclassifications can bias the estimated associations 
and the question is, whether men with MetS and diabetes 
are systematically more likely to be classified as childless. 
For instance if men with low socioeconomic status are 
systematically more likely childless due to being single, 
and at higher risk of disease, this could lead to an overes-
timation of the association between infertility and MetS/
diabetes. However, by adjusting for socioeconomic status, 
and associated lifestyle factors as well as by confirming 
our findings in sensitivity analyses based on married men 
only, this source of bias was minimised.
Unfortunately, comparison of male participants versus 
male non-participants in either the MDC or the MDC-CC 
have not been done, but a study from 2001 concluded that 
mortality for men and women combined was higher in 
non-participants than in participants which could reflect 
healthy selection bias in the cohort.21 Selection bias 
occurs when conditioning on a common effect of expo-
sure and outcome—in this case conditioning on survival 
of participants. In our analyses, selection bias could occur 
if fatherhood status and MetS or diabetes are directly or 
indirectly related to preterm death before initial enrol-
ment into the cohort. For example, if childless men are 
more likely to have lower socioeconomic status (which 
itself is associated with increased risk of preterm death), 
and if men with MetS or diabetes are more likely to have 
comorbidities (which is related to preterm death).
COnClusIOn
In conclusion, our study showed a higher risk of MetS and 
diabetes among childless middle-aged men that could not 
be explained by differences in lifestyle, sociodemographic 
characteristics or health-seeking behaviour. This may 
support the hypothesis that a man’s reproductive health 
is closely intertwined with his somatic health, however 
due to the nature of the cross-sectional design, where 
information on exposure and outcome is collected simul-
taneously, reverse causation cannot be excluded. While 
using childlessness as a proxy of male infertility may cause 
misclassification bias, it may still provide insight into a 
man’s risk of disease. The simple objective measure of 
exposure enables for future studies to examine the asso-
ciation between male reproductive health and somatic 
health in large population-based cohorts.
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